Medicine & Life Sciences
Biomedical Technology Assessment
100%
Registries
62%
Uncertainty
54%
Advisory Committees
41%
Technology
17%
Biomedical Technology
16%
Cost-Benefit Analysis
11%
Stakeholder Participation
9%
Safety
7%
Budgets
7%
Routine Diagnostic Tests
6%
Pharmaceutical Preparations
5%
Economics
5%
Research Personnel
4%
Social Sciences
technology assessment
93%
medical services
36%
health
35%
uncertainty
35%
evidence
32%
funding
28%
additional evidence
13%
subsidy
10%
stakeholder
7%
diagnostic test
6%
costs
5%
pharmaceutical
4%
decision maker
4%
new technology
4%
website
4%
budget
4%
dialogue
3%
time
3%
drug
3%
evaluation
2%
economics
2%
Group
1%